bioAffinity Technologies, Inc.
BIAF
$1.62
$0.053.19%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -152.45% | -92.43% | -35.61% | -25.02% | 12.66% |
| Total Depreciation and Amortization | -25.05% | -25.08% | 3.34% | 3.23% | 162.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,415.67% | 345.28% | 15.12% | -0.17% | -0.38% |
| Change in Net Operating Assets | -686.78% | -81.58% | 165.74% | 141.43% | -108.83% |
| Cash from Operations | -45.11% | -72.75% | 30.02% | -3.77% | -11.53% |
| Capital Expenditure | 138.30% | 52.65% | -22.71% | -100.00% | -4,600.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 138.30% | 52.65% | -22.71% | -100.00% | 99.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 147.36% | -84.73% | -56.93% | -7.31% | -79.13% |
| Issuance of Common Stock | 325.15% | -- | -54.51% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -80.65% | -- | -- | -- | -- |
| Cash from Financing | 458.16% | 3,413.72% | -48.89% | 2,489.03% | 3,395.08% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15,461.07% | 121.68% | -79.32% | 120.66% | 98.81% |